Pompe disease is a rare, inherited lysosomal storage disorder caused by mutations in the GAA gene, leading to deficient acid alpha-glucosidase (GAA) enzyme activity. This results in excessive glycogen accumulation in muscle cells, causing progressive weakness and respiratory complications. Over the years, enzyme replacement therapy (ERT) has been the standard of care, but emerging...